Zepatier

FDA issues safety warning for newer hepatitis C drugs following patient deaths
Biopharma Dive
Wed, 08/28/19 - 11:02 pm
FDA
hepatitis C
FAERS
AbbVie
Mavyret
Merck
Zepatier
Gilead Sciences
Vosevi
Merck’s 60% price cut for hepatitis C drug nets company a big sales opportunity
Marketwatch
Wed, 08/8/18 - 12:00 am
Merck
Express Scripts
hepatitis C
Zepatier
Merck touts a 60% price cut, but the drug is outdated and on the way out
Marketwatch
Sat, 07/21/18 - 02:09 pm
Merck
Zepatier
hepatitis C
drug pricing
3 Bright Spots in Merck's Q3 Results
Motley Fool
Sun, 10/29/17 - 10:14 am
Merck
earnings
Keytruda
Zepatier
animal health
Merck targets high-risk military veterans for hepatitis C lessons
Fierce Pharma
Mon, 10/16/17 - 11:55 am
Merck
hepatitis C
Zepatier
10 Reasons Merck Could Be the World's Most Perfect Stock
Motley Fool
Fri, 04/21/17 - 11:43 am
Merck
Keytruda
Zepatier
biosimilars
M&A
drug pricing
animal health
This Was, Unquestionably, the Most Disappointing Drug Launch of 2016
Motley Fool
Tue, 01/31/17 - 09:51 am
drug launches
Merck
Zepatier
hepatitis C
Zepatier Should Boost Merck’s Profit Margins in the Future
Market Realist
Mon, 01/2/17 - 12:00 pm
Merck
Zepatier
hepatitis C
Merck's Mixed Q1 Results Are Marred By 1 Disappointing Drug Debut
Motley Fool
Mon, 05/9/16 - 10:22 am
Merck
earnings
Zepatier
hepatitis C
'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier
BioPharma Dive
Mon, 05/2/16 - 10:11 am
drug pricing
Merck
hepatitis C
Zepatier
Seven New York insurers end restrictions on coverage for hepatitis C drugs
BioPharma Dive
Wed, 04/27/16 - 09:20 am
New York
insurers
hepatitis C
Merck
Zepatier
Gilead Sciences
Harvoni
New analysis boosts cost-effectiveness argument for Merck's Zepatier
BioPharma Dive
Wed, 04/20/16 - 06:37 pm
Merck
Zepatier
hepatitis C
Harvoni
Gilead Sciences
Merck's 'no patient left behind' approach to hepatitis C
BioPharma Dive
Mon, 04/18/16 - 09:00 pm
Merck
hepatitis C
Zepatier
Gilead Sciences
Sovaldi
Harvoni
Merck’s ZEPATIER™ (Elbasvir and Grazoprevir) Showed Superiority on Efficacy and Safety Endpoints Compared to Sofosbuvir Plus Peginterferon and Ribavirin Treatment Regimen in Phase 3 Trial
Yahoo
Thu, 04/14/16 - 09:41 am
Merck
Zepatier
elbasvir/grazoprevir
hepatitis C
Gilead Sciences: ‘Another Pretender to Hepatitis C Throne Seems to Be Suffering the AbbVie Fate’
Barron's
Mon, 03/28/16 - 11:32 am
Gilead Sciences
hepatitis C
Merck
Zepatier
Harvoni
Will Merck Encroach On Gilead's Harvoni Territory?
Yahoo/Benzinga
Tue, 02/23/16 - 05:44 pm
Merck
Gilead
Harvoni
AbbVie
hepatitis C
Viekira Pak
Zepatier
Merck's new hep C contender Zepatier faces a long runway, but 2017 could bring takeoff
Fierce Pharma Marketing
Wed, 02/17/16 - 10:33 am
Merck
hepatitis C
Zepatier
Express Scripts
Curing Hepatitis C: How Gilead Sciences Plans to Beat Merck
Motley Fool
Tue, 02/9/16 - 09:21 am
hepatitis C
Merck
Gilead Sciences
Zepatier
Harvoni
Merck Takes on Gilead With Sharply Lower Hepatitis C Drug Price
TheStreet.com
Fri, 01/29/16 - 10:34 am
Merck
Gilead Sciences
hepatitis C
Zepatier
drug pricing